ONCOLOGY_GUIDELINES

ONCOLOGY GUIDELINES

When the tumor
extends its feet from
all sides of its body
into the veins, the
sickness produces
the picture of a crab
.
- Galen, (130-200)

I.      SOLID TUMORS
A. BREAST CANCER
    a. Breast cancer (nccn, 2006)
    b. Breast cancer surveillance (asco, 2003)
    c. Radiotherapy post-mastectomy (asco, 2005)

B. CHEST AND LUNGS
    a. Small Cell Lung Cancer (nccn, 2006)
    b. Non-small Cell Lung Cancer (nccn, 2006)
        Unresectable (asco, 1997, 2003)

C. CNS TUMORS (nccn, 2006 )

D. GASTROINTESTINAL MALIGNANCIES
     a. ANAL CANCER (nccn, 2006 )
     b. COLORECTAL CANCER
         Colon Cancer (nccn, 2006 )
         Adjuvant chemo for stage II (asco, 2004)
         Rectal cancer (nccn, 2006 )
         Surveillance (asco, 2000)
     c. ESOPHAGEAL CANCER (nccn, 2006 )
     d. GASTRIC CANCER (nccn, 2006 )
     e. HEPATOBILIARY CANCERS (nccn, 2006 )
         HEPATOMA (bsg, 2003)
     f. PACNREATIC CANCERS (aga,1999), (nccn, 2006 )

E. GYNECOLOGIC MALIGNANCIES
    a. CERVICAL CANCER (nccn, 200 6 )
    b. OVARIAN CANCER (nccn, 2006 )
    c. UTERINE CANCERS (nccn, 200 6 )

F. HEAD & NECK CANCERS (nccn, 2005)

G. MUSCULOSKELETAL
     a. BONE CANCER (nccn, 2006 )
     b. SOFT TISSUE SARCOMA (nccn, 2006 )

H. NEUROENDOCRINE TUMORS (nccn, 2006 )
    THYROID CANCER (aace/aaes, 2001 ), (nccn, 2005)
                              (ata, 1996), (bta, 2002)

I. UROLOGIC MALIGNANCIES
   a. BLADDER CANCER (nccn, 20 07 )
   b. KIDNEY CANCER (nccn, 2007 )
   c. PROSTATE CANCER (nccn, 2005)
       Hormonal Therapy (asco, 2004)

J. SKIN CANCER
   a. BASAL CELL & SQUAMOUS CELL CANCER (nccn, 2006)
   b. MELANOMA (nccn, 2006 )
   c. MERKLE CELL CARCINOMA (nccn, 2006 )
   d. DERMATOFIBROSARCOMA PROTRUBERANS (nccn, 2006)

K. OCCULT PRIMARY/CUPS OF UNKNOWN PRIMARY SITE (nccn, 2005)

II.      NON-SOLID TUMORS & LYMPHOMAS
A. LEUKEMIAS
    a. ACUTE MYELOID LEUKEMIA (nccn, 2005)
    b. CHRONIC MYELOGENOUS LEUKEMIA (nccn, 2005)

B. LYMPHOMAS
    a. HODGKIN’S DISEASE (nccn,2005)
    b. NON-HODGKIN’S LYMPHOMA (nccn,2006 )

C. OTHERS
    a. MYELODYSPLASTIC SYNDROME (nccn, 2006)
b. MULTIPLE MYELOMA (nccn, 2005)
    Bisphosphonates in Multiple myeloma (asco, 2003)

III.     SCREENING AND DIAGNOSTICS
AMERICAN CANCER SOCIETY (ACS) SCREENING GUIDELINES
AMERICAN ACADEMY OF FAMILY PHYSICIANS (aafp, 2001)
Bladder cancer (uspstf, 2004)
BRCA Mutation testing for breast and ovarian cancer (uspstf, 2005)
Breast cancer, screening (nccn, 2006), (uspstf, 2002)
Breast cancer risk reduction (chemoprevention) (nccn, 2006), (uspstf, 2002)
Breast and colon cancer (asco, 2003)
Breast and colon cancer, tumor markers (asco, 1996)
Breast & ovarian cancer high risk genetic testing (nccn, 2006), (uspstf, 2004)
Cervical cancer (nccn, 2006), (uspstf, 2003)
Colorectal screening (nccn, 2006 ), (aga, 2003), (uspstf, 2002)
Lung cancer (uspstf, 2004)
Oral cancer (uspstf, 2004)
Ovarian (uspstf , 2004)
Pancreatic cancer (uspstf, 2004)
Prostate cancer (nccn, 2006 ), (uspstf, 2002)
Skin cancer (uspstf, 2001)
Testicular cancer (uspstf, 2004)
Vitamin supplementation to prevent cancer (& CAD) (uspstf, 2003)

IV.    SUPPORTIVE CARE
Anemia, Cancer & Treatment-Related (nccn, 2006 )
Antiemetics (asco, 1999), (nccn, 2005)
Bisphosphonates & Bone Health in Breast Cancer (asco, 2005)
Colony Stimulating Factors (asco, 1994)
Distress Management (nccn, 2005)
Erythropoietin (asco, 2002)
Fatigue, Cancer-Related (nccn, 2005)
Fever & Neutropenia (nccn, 2005), (idsa, 2002)
Growth Factors, Myeloid (nccn, 2005)
Intravascular Catheter-Related Infections (idsa, 2001)
Pain, Cancer (ahcpr), (nccn, 2005)
Palliative Care (nccn, 2005)
Platelet trasnfusion (asco, 2003)
Protectants, chmotherapy & radiotherapy (asco, 2003)
Senior Adult Oncology (nccn, 2005)